This country profile provides an overview of Ethiopia’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
75%
Blinding trachoma
71%
Intestinal worms
70%
Bilharzia
71%
River blindness
81%
49.87 million people received treatment in Ethiopia in 2017 19.93 million people did not receive treatment in Ethiopia in 2017

Priorities for progress in Ethiopia

  • Ethiopia is encouraged to further increase overall coverage for preventive chemotherapy, with systematic annual implementation of all components, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 45% in 2016 to 75% in 2017.

People needing treatment
5.63m
People receiving treatment
4.22m

Blinding trachoma

Treatment coverage increased from to 64% in 2016 to 71% in 2017.

People needing treatment
69.8m
People receiving treatment
49.87m

Intestinal worms

Treatment coverage increased 41% in 2016 to 70% in 2017.

Pre-sch and school-aged children needing treatment
26.02m
Pre-school and school-aged children receiving treatment
18.14m

Bilharzia

Treatment coverage increased from 36% in 2016 to 71% in 2017.

School-aged children needing treatment
7.08m
School-aged children receiving treatment
5.02m

River blindness

Treatment coverage increased from 80% in 2016 to 81% in 2017.

People needing treatment
17.51m
People receiving treatment
14.16m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Ethiopia.